Ken Griffin's position in Xeris Biopharma Holdings is currently worth $4.17 Million. That's 0.00% of their equity portfolio (1719th largest holding). The first Xeris Biopharma Holdings trade was made in Q2 2018. Since then Ken Griffin bought shares nine more times and sold shares on ten occasions. The stake costed the investor $2.69 Million, netting the investor a gain of 55% so far.